BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 35211401)

  • 1. What Clonal Hematopoiesis Can Teach Us About MDS.
    Chan ICC; Wiley BJ; Bolton KL
    Front Oncol; 2022; 12():794021. PubMed ID: 35211401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early detection and intervention of clonal hematopoiesis for preventing hematological malignancies.
    Ye B; Sheng Y; Zhang M; Hu Y; Huang H
    Cancer Lett; 2022 Jul; 538():215691. PubMed ID: 35469959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How predictive is the finding of clonal hematopoiesis for the development of myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML)?
    Steensma DP
    Best Pract Res Clin Haematol; 2021 Dec; 34(4):101327. PubMed ID: 34865699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical manifestations of clonal hematopoiesis: What has SF3B1-mutant MDS taught us?
    Todisco G; Moura PL; Hellström-Lindberg E
    Semin Hematol; 2022 Jul; 59(3):150-155. PubMed ID: 36115692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal hematopoiesis and preleukemia-Genetics, biology, and clinical implications.
    Hartmann L; Metzeler KH
    Genes Chromosomes Cancer; 2019 Dec; 58(12):828-838. PubMed ID: 30939217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncovering perturbations in human hematopoiesis associated with healthy aging and myeloid malignancies at single-cell resolution.
    Ainciburu M; Ezponda T; Berastegui N; Alfonso-Pierola A; Vilas-Zornoza A; San Martin-Uriz P; Alignani D; Lamo-Espinosa J; San-Julian M; Jiménez-Solas T; Lopez F; Muntion S; Sanchez-Guijo F; Molero A; Montoro J; Serrano G; Diaz-Mazkiaran A; Lasaga M; Gomez-Cabrero D; Diez-Campelo M; Valcarcel D; Hernaez M; Romero JP; Prosper F
    Elife; 2023 Jan; 12():. PubMed ID: 36629404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myelodysplastic syndromes are multiclonal diseases derived from hematopoietic stem and progenitor cells.
    Luo B; Dong F; Qin T; Zhang Q; Bai H; Wang J; Jia Y; Ma S; Jiang E; Cheng T; Xiao Z; Ema H
    Exp Hematol Oncol; 2022 May; 11(1):28. PubMed ID: 35578364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute myeloid leukemia derived from lympho-myeloid clonal hematopoiesis.
    Thol F; Klesse S; Köhler L; Gabdoulline R; Kloos A; Liebich A; Wichmann M; Chaturvedi A; Fabisch J; Gaidzik VI; Paschka P; Bullinger L; Bug G; Serve H; Göhring G; Schlegelberger B; Lübbert M; Kirchner H; Wattad M; Kraemer D; Hertenstein B; Heil G; Fiedler W; Krauter J; Schlenk RF; Döhner K; Döhner H; Ganser A; Heuser M
    Leukemia; 2017 Jun; 31(6):1286-1295. PubMed ID: 27881874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Immune Signaling Pathways in Clonal Hematopoiesis.
    Azrakhsh NA; Mensah-Glanowska P; Sand K; Kittang AO
    Curr Med Chem; 2019; 26(28):5262-5277. PubMed ID: 30907306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal Hematopoiesis and therapy related MDS/AML.
    Desai P; Roboz GJ
    Best Pract Res Clin Haematol; 2019 Mar; 32(1):13-23. PubMed ID: 30927970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of p53 in regulation of hematopoiesis in health and disease.
    Barajas S; Cai W; Liu Y
    Curr Opin Hematol; 2022 Jul; 29(4):194-200. PubMed ID: 35787548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal Hematopoiesis and risk of Acute Myeloid Leukemia.
    Desai P; Hassane D; Roboz GJ
    Best Pract Res Clin Haematol; 2019 Jun; 32(2):177-185. PubMed ID: 31203999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and Pathogenesis of Myelodysplastic Syndrome.
    Rotter LK; Shimony S; Ling K; Chen E; Shallis RM; Zeidan AM; Stahl M
    Cancer J; 2023 May-Jun 01; 29(3):111-121. PubMed ID: 37195766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline predisposition for clonal hematopoiesis.
    Kubota Y; Viny AD
    Semin Hematol; 2024 Feb; 61(1):61-67. PubMed ID: 38311514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the genetics of high-risk childhood B-progenitor acute lymphoblastic leukemia and juvenile myelomonocytic leukemia: implications for therapy.
    Loh ML; Mullighan CG
    Clin Cancer Res; 2012 May; 18(10):2754-67. PubMed ID: 22589484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal hematopoiesis and risk for hematologic malignancy.
    Warren JT; Link DC
    Blood; 2020 Oct; 136(14):1599-1605. PubMed ID: 32736382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathophysiology of hematological malignancies associated with ASXL1 mutations].
    Fujino T
    Rinsho Ketsueki; 2022; 63(6):561-572. PubMed ID: 35831189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clonal evolution of myeloid malignancies].
    Kon A
    Rinsho Ketsueki; 2020; 61(9):1120-1129. PubMed ID: 33162507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Immunodeficiency Virus and Clonal Hematopoiesis.
    Vorri SC; Christodoulou I; Karanika S; Karantanos T
    Cells; 2023 Feb; 12(5):. PubMed ID: 36899822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Navigating the contested borders between myelodysplastic syndrome and acute myeloid leukemia.
    Ambinder AJ; DeZern AE
    Front Oncol; 2022; 12():1033534. PubMed ID: 36387170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.